Search Login Register

tartrate salt cis-1R-(4'-pyrrolidinoethoxyphenyl)-2S-phenyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene (Lasofoxifene) Summary

Description: structure in first source

Also Known As: Lasofoxifene; cis-1R-(4'-pyrrolidinoethoxyphenyl)-2S-phenyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene, tartrate salt; CP 336156; CP-336,156; LAS estrogen receptor modulator

Networked: 61 relevant articles (9 outcomes, 14 trials/studies) for this Bio-Agent

Key Diseases for which tartrate salt cis-1R-(4'-pyrrolidinoethoxyphenyl)-2S-phenyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene is Relevant

  1. Postmenopausal Osteoporosis : 3 outcomes 2 studies in 18 results
  2. Osteoporosis : 2 outcomes 4 studies in 29 results
  3. Atrophy : 2 outcomes 1 study in 8 results
  4. Breast Neoplasms (Breast Cancer) : 1 outcome 4 studies in 18 results
  5. Stroke (Strokes) : 1 outcome 2 studies in 7 results
Show All >>

Drugs Related to tartrate salt cis-1R-(4'-pyrrolidinoethoxyphenyl)-2S-phenyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene

  1. Selective Estrogen Receptor Modulators (SERM)
  2. Raloxifene (Evista)
  3. bazedoxifene acetate
  4. 2- (4- (4- chloro- 1,2- diphenyl- but- 1- enyl)phenoxy)ethanol
  5. Estrogens (Estrogen)
  6. Tamoxifen
  7. Toremifene (Fareston)
  8. Steroid Receptors (Steroid Receptor)
  9. Estrogen Receptors
  10. Aromatase Inhibitors
Show All >>

Therapies Related to tartrate salt cis-1R-(4'-pyrrolidinoethoxyphenyl)-2S-phenyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene

  1. Stents
  2. Chemoprevention

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.